| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Jewish Association On Aging is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hammer Medical is a Des Moines, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DiscoveRx is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fremont, CA. To find more information about DiscoveRx, please visit www.discoverx.com
CAnCare of Houston is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.